Overview

Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants

Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, randomized, double-masked, controlled study to evaluate the safety and efficacy of fluocinolone acetonide (FA) intravitreal implants for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye. An additional objective is to compare the safety and efficacy of two doses of fluocinolone acetonide.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Bausch & Lomb Incorporated
Treatments:
Fluocinolone Acetonide